WIB Board of Directors
| President |
Cassidy Cantin, Consultant, Latham BioPharm Group |
| |
|
| President Elect 2018 |
Rachel Kopper, Associate Director, Business Operations and Finance, Knopp Biosciences, LLC |
| |
|
President Emeritus
|
Dawn Hocevar, President/CEO, CTBio
|
| |
|
| Treasurer |
Debra Chamra, MA, CPA ,Life Sciences Financial Consultant |
| |
|
| Board Member |
Pat Larrabee, MS, President, Facility Logix, LLC
|
| |
|
| Board Member |
Simone Fishburn, VP and Executive Editor, BioCentury Inc. |
| |
|
| Board Member |
Paula Kasler, JD, Legal Counsel to Life Sciences Companies |
| |
|
| Board Member |
Mona Chadha, MBA, Chief Strategy Officer, Bay Area at Dignity Health |
| |
|
| Board Member |
Fran Schulz, BS, CPA, Partner, Ernst & Young |
| |
|
| Board Member |
Debra Bowes, BS, MBEE, President, Chevy Chase BioPartners |
| |
|
| Board Member |
Lily Rin-Laures, Partner at Marshall Gerstein & Borun LLP, Intellectual Property Law |
| |
|
| Board Member |
Theresa McNeely, SVP, Corporate Communications and Investor Relations, Akebia Therapeutics |
| |
|
| Board Member |
Dimitra Georganopoulou, PhD, Innovation and Commercialization Officer of INVO |
| |
|
| Board Member |
Kristi Sarno, Senior Consultant, Latham BioPharm Group |
| |
|
| Board Member |
Anggie Becorest, President & Co-founder, Lab Asset Manager |
|
Print Page